참고문헌
- Almand, B., Clark, J.I., Nikitina, E., van Beynen, J., English, N.R., Knight, S.C., Carbone, D.P., and Gabrilovich, D.I. (2001). Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol.166, 678-689. https://doi.org/10.4049/jimmunol.166.1.678
- Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N.P., and Zanovello, P. (2000). Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96, 3838-3846.
- Bronte, V., Serafini, P., Mazzoni, A., Segal, D.M., and Zanovello, P. (2003). L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24, 302-306.
- Cai, W., Qin, A., Guo, P., Yan, D., Hu, F., Yang, Q., Xu, M., Fu, Y., Zhou, J., and Tang, X. (2013). Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J. Clin. Immunol. 33, 798-808. https://doi.org/10.1007/s10875-012-9861-2
- Chen, S., Akbar, S.M., Abe, M., Hiasa, Y., and Onji, M. (2011). Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin. Exp. Immunol. 166, 134-142. https://doi.org/10.1111/j.1365-2249.2011.04445.x
- Condamine, T., and Gabrilovich, D.I. (2011). Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32, 19-25. https://doi.org/10.1016/j.it.2010.10.002
- Corzo, C.A., Cotter, M.J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T.V., McCaffrey, J.C., and Gabrilovich, D.I. (2009). Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182, 5693-5701. https://doi.org/10.4049/jimmunol.0900092
- Das, A., Hoare, M., Davies, N., Lopes, A.R., Dunn, C., Kennedy, P.T., Alexander, G., Finney, H., Lawson, A., Plunkett, F.J., et al. (2008). Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205, 2111-2124. https://doi.org/10.1084/jem.20072076
- Desmet, V.J., Gerber, M., Hoofnagle, J.H., Manns, M., and Scheuer, P.J. (1994). Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19, 1513-1520. https://doi.org/10.1002/hep.1840190629
- European Association of the Study of the Liver (2012). 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines. Liver Int. 32 Suppl 1, 2-8.
- Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., and Rivoltini, L. (2007). Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546-2553. https://doi.org/10.1200/JCO.2006.08.5829
- Filipazzi, P., Huber, V., and Rivoltini, L. (2012). Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol. Immunother. 61, 255-263. https://doi.org/10.1007/s00262-011-1161-9
- Gabrilovich, D.I., and Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174. https://doi.org/10.1038/nri2506
- Hoechst, B., Ormandy, L.A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M.P., Greten, T.F., and Korangy, F. (2008). A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135, 234-243. https://doi.org/10.1053/j.gastro.2008.03.020
- Kong, Y.Y., Fuchsberger, M., Xiang, S.D., Apostolopoulos, V., and Plebanski, M. (2013). Myeloid derived suppressor cells and their role in diseases. Curr. Med. Chem. 20, 1437-1444. https://doi.org/10.2174/0929867311320110006
- Kotsakis, A., Harasymczuk, M., Schilling, B., Georgoulias, V., Argiris, A., and Whiteside, T.L. (2012). Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J. Immunol. Methods 381, 14-22. https://doi.org/10.1016/j.jim.2012.04.004
- Lauer, G.M. (2013). Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies. J. Infect. Dis. 207 Suppl 1, S7-S12. https://doi.org/10.1093/infdis/jis762
- Lavanchy, D. (2009). The global burden of hepatitis C. Liver Int. 29 Suppl 1, 74-81.
- Lavanchy, D. (2011). Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 17, 107-115. https://doi.org/10.1111/j.1469-0691.2010.03432.x
- Lechner, F., Gruener, N.H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A.R., Cerny, A., Phillips, R., Ferrari, C., Pape, G.R., et al. (2000). CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 2479-2487. https://doi.org/10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B
- Macatangay, B.J., Landay, A.L., and Rinaldo, C.R. (2012). MDSC: a new player in HIV immunopathogenesis. AIDS 26, 1567-1569. https://doi.org/10.1097/QAD.0b013e328355e682
- Neumann-Haefelin, C., and Thimme, R. (2013). Adaptive immune responses in hepatitis C virus infection. Curr. Top. Microbiol. Immunol. 369, 243-262.
- Ochoa, A.C., Zea, A.H., Hernandez, C., and Rodriguez, P.C. (2007). Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13, 721s-726s. https://doi.org/10.1158/1078-0432.CCR-06-2197
- Qin, A., Cai, W., Pan, T., Wu, K., Yang, Q., Wang, N., Liu, Y., Yan, D., Hu, F., Guo, P., et al. (2013). Expansion of monocytic myeloidderived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87, 1477-1490. https://doi.org/10.1128/JVI.01759-12
- Ramachandran, I.R., Martner, A., Pisklakova, A., Condamine, T., Chase, T., Vogl, T., Roth, J., Gabrilovich, D., and Nefedova, Y. (2013). Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow. J. Immunol. 190, 3815-3823. https://doi.org/10.4049/jimmunol.1203373
- Rodriguez, P.C., and Ochoa, A.C. (2008). Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222, 180-191. https://doi.org/10.1111/j.1600-065X.2008.00608.x
- Rodriguez, P.C., Zea, A.H., DeSalvo, J., Culotta, K.S., Zabaleta, J., Quiceno, D.G., Ochoa, J.B., and Ochoa, A.C. (2003). L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J. Immunol. 171, 1232-1239. https://doi.org/10.4049/jimmunol.171.3.1232
- Sandalova, E., Laccabue, D., Boni, C., Watanabe, T., Tan, A., Zong, H.Z., Ferrari, C., and Bertoletti, A. (2012). Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells. Gastroenterology 143, 78-87 e73. https://doi.org/10.1053/j.gastro.2012.03.041
- Srivastava, M.K., Sinha, P., Clements, V.K., Rodriguez, P., and Ostrand-Rosenberg, S. (2010). Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70, 68-77.
- Tacke, R.S., Lee, H.C., Goh, C., Courtney, J., Polyak, S.J., Rosen, H.R., and Hahn, Y.S. (2012). Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55, 343-353. https://doi.org/10.1002/hep.24700
- Thimme, R., Oldach, D., Chang, K.M., Steiger, C., Ray, S.C., and Chisari, F.V. (2001). Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395-1406. https://doi.org/10.1084/jem.194.10.1395
- Vasquez-Dunddel, D., Pan, F., Zeng, Q., Gorbounov, M., Albesiano, E., Fu, J., Blosser, R.L., Tam, A.J., Bruno, T., Zhang, H., et al. (2013). STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J. Clin. Invest. 123, 1580-1589. https://doi.org/10.1172/JCI60083
- Vollbrecht, T., Stirner, R., Tufman, A., Roider, J., Huber, R.M., Bogner, J.R., Lechner, A., Bourquin, C., and Draenert, R. (2012). Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26, F31-37. https://doi.org/10.1097/QAD.0b013e3283558446
- Xu, D., Fu, J., Jin, L., Zhang, H., Zhou, C., Zou, Z., Zhao, J.M., Zhang, B., Shi, M., Ding, X., et al. (2006). Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177, 739-747. https://doi.org/10.4049/jimmunol.177.1.739
- Yang, B., Wang, X., and Ren, X. (2012). Amino acid metabolism related to immune tolerance by MDSCs. Int. Rev. Immunol. 31, 177-183. https://doi.org/10.3109/08830185.2012.679989
- Young, M.R., Newby, M., and Wepsic, H.T. (1987). Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47, 100-105.
- Zea, A.H., Rodriguez, P.C., Atkins, M.B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005). Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65, 3044-3048. https://doi.org/10.1158/0008-5472.CAN-04-4505
- Zhang, Z., Zhang, J.Y., Wherry, E.J., Jin, B., Xu, B., Zou, Z.S., Zhang, S.Y., Li, B.S., Wang, H.F., Wu, H., et al. (2008). Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134, 1938-1949, 1949 e1931-1933. https://doi.org/10.1053/j.gastro.2008.03.037
- Zhang, J.Y., Zhang, Z., Lin, F., Zou, Z.S., Xu, R.N., Jin, L., Fu, J.L., Shi, F., Shi, M., Wang, H.F., et al. (2010). Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51, 81-91. https://doi.org/10.1002/hep.23273
- Zou, Z., Li, B., Xu, D., Zhang, Z., Zhao, J.M., Zhou, G., Sun, Y., Huang, L., Fu, J., Yang, Y., et al. (2009). Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J. Clin. Gastroenterol. 43, 182-190. https://doi.org/10.1097/MCG.0b013e3181624464
피인용 문헌
- PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment vol.6, pp.1, 2016, https://doi.org/10.1038/srep39296
- Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0170516
- The Role of Myeloid-Derived Suppressor Cells in Viral Infection vol.30, pp.2, 2017, https://doi.org/10.1089/vim.2016.0125
- Current progress in host innate and adaptive immunity against hepatitis C virus infection vol.11, pp.4, 2017, https://doi.org/10.1007/s12072-017-9805-2
- Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease vol.11, pp.2, 2016, https://doi.org/10.1371/journal.pone.0149948
- In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition vol.29, pp.18, 2015, https://doi.org/10.1097/QAD.0000000000000871
- Analysis of Monocytic and Granulocytic Myeloid-Derived Suppressor Cells Subsets in Patients with Hepatitis C Virus Infection and Their Clinical Significance vol.2015, 2015, https://doi.org/10.1155/2015/385378
- Significant Roles of Regulatory T Cells and Myeloid Derived Suppressor Cells in Hepatitis B Virus Persistent Infection and Hepatitis B Virus-Related HCCs vol.16, pp.2, 2015, https://doi.org/10.3390/ijms16023307
- Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection vol.150, pp.2, 2017, https://doi.org/10.1111/imm.12680
- Phenotype, development, and biological function of myeloid-derived suppressor cells vol.5, pp.2, 2016, https://doi.org/10.1080/2162402X.2015.1004983
- Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8+ T cell responses during acute Friend retrovirus infection vol.14, pp.1, 2017, https://doi.org/10.1186/s12977-017-0364-3
- Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and Fibrosis vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0119662
- Hepatitis C Virus–Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1 vol.196, pp.5, 2016, https://doi.org/10.4049/jimmunol.1501881
- Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells vol.11, pp.10, 2015, https://doi.org/10.1371/journal.ppat.1005191
- Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases vol.66, pp.8, 2017, https://doi.org/10.1007/s00262-017-2035-6
- Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals vol.30, pp.10, 2016, https://doi.org/10.1097/QAD.0000000000001083
- IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS vol.39, pp.4, 2017, https://doi.org/10.1080/08923973.2017.1320670
- Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease vol.36, pp.6, 2014, https://doi.org/10.1007/s11357-014-9729-x
- Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway vol.148, pp.4, 2016, https://doi.org/10.1111/imm.12616
- Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalling pp.13520504, 2018, https://doi.org/10.1111/jvh.13024
- The role of myeloid-derived suppressor cells in chronic infectious diseases and the current methodology available for their study pp.07415400, 2018, https://doi.org/10.1002/JLB.MR0618-233R
- Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections vol.8, pp.1664-3224, 2018, https://doi.org/10.3389/fimmu.2017.01895
- Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma pp.01466615, 2019, https://doi.org/10.1002/jmv.25428
- Myeloid-Derived Suppressor Cells Regulate Immune Response in Patients with Chronic Hepatitis B Virus Infection through PD-1–Induced IL-10 vol.193, pp.11, 2014, https://doi.org/10.4049/jimmunol.1400849
- HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function vol.4, pp.None, 2014, https://doi.org/10.1038/s41421-018-0052-z
- Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients vol.145, pp.2, 2014, https://doi.org/10.1007/s00432-018-02825-8
- MDSCs in infectious diseases: regulation, roles, and readjustment vol.68, pp.4, 2014, https://doi.org/10.1007/s00262-018-2277-y
- Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence vol.8, pp.4, 2014, https://doi.org/10.3390/cells8040376
- Myeloid‐derived suppressor cells expansion is closely associated with disease severity and progression in HBV‐related acute‐on‐chronic liver failure vol.91, pp.8, 2019, https://doi.org/10.1002/jmv.25466
- Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity vol.118, pp.None, 2014, https://doi.org/10.1016/j.molimm.2019.12.012
- Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity vol.131, pp.6, 2014, https://doi.org/10.1172/jci144734
- Swertianolin ameliorates immune dysfunction in sepsis via blocking the immunosuppressive function of myeloid- derived suppressor cells vol.65, pp.3, 2021, https://doi.org/10.4081/ejh.2021.3292
- Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19 vol.144, pp.None, 2021, https://doi.org/10.1016/j.biopha.2021.112346